# Mumbai-based drugmaker has completed more than three months of detailed due diligence.

*business · news · 2026-04-10 · Outlook Business*

## Key points

- Sun Pharma is preparing a $12 billion all-cash bid to acquire Organon & Co.
- This would be the largest overseas acquisition ever attempted by an Indian pharmaceutical company.
- Sun Pharma has secured backing from JPMorgan, MUFG, Standard Chartered, and Citi for the bid.
- Organon carries $9.5 billion in debt inherited from its 2021 spinoff from MSD.
- Two other international consortiums are also competing to acquire Organon, with Morgan Stanley advising.

**Companies:** Sun Pharmaceutical Industries, Organon & Co, MSD (Merck Sharp & Dohme), JPMorgan, MUFG, Standard Chartered, Citi
**Countries:** India, United States

[Read the full story on Outlook Business](https://www.outlookbusiness.com/corporate/sun-pharma-moves-closer-to-12-bn-organon-acquisition-banks-line-up-financing)

---

Canonical: https://newsio.io/n/0af8f64c-bbc3-49b7-94a0-e1c307a9ba83/mumbai-based-drugmaker-has-completed-more-than-three-months-of-detailed-due-dili
Summarized by Newsio from Outlook Business. https://newsio.io/how-it-works